Vera Therapeutics (VERA) Non-Current Assets (2020 - 2026)
Vera Therapeutics (VERA) posted Non-Current Assets of $5.9 million for Q1 2026, up 1.49% on a QoQ basis from $5.8 million in Q4 2025, and up 45.12% year-over-year from $4.1 million in Q1 2025.
Vera Therapeutics (VERA) Non-Current Assets (2020 - 2026) Analysis & Trends
Vera Therapeutics' Non-Current Assets history runs 7 years deep, the most recent figure standing at $5.9 million for Q1 2026.
- Quarterly Non-Current Assets rose 45.12% year-over-year to $5.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.2 million (up 62.0% YoY) and the FY2025 annual result came in at $5.8 million, up 31.08% from the prior year.
- Non-Current Assets was $5.9 million for Q1 2026 at Vera Therapeutics, up from $5.8 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $7.2 million in Q1 2022 and bottomed at $2.5 million in Q2 2024.
- A 5-year average of $5.1 million and a median of $5.2 million in 2023 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets surged 2367.92% — and 2024, when it slumped 44.26%.
- Vera Therapeutics' Non-Current Assets stood at $5.7 million in 2022, then sank by 38.59% to $3.5 million in 2023, then rose by 26.68% to $4.5 million in 2024, then jumped by 31.08% to $5.8 million in 2025, then grew by 1.49% to $5.9 million in 2026.
- Business Quant data shows VERA's Non-Current Assets at $5.9 million in Q1 2026, $5.8 million in Q4 2025, and $6.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Vera Therapeutics | 2.60 Bn | 2.60 Bn | - | 5.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.94 Mn |
| Dec 31, 2025 | 5.85 Mn |
| Sep 30, 2025 | 6.19 Mn |
| Jun 30, 2025 | 7.17 Mn |
| Mar 31, 2025 | 4.09 Mn |
| Dec 31, 2024 | 4.46 Mn |
| Sep 30, 2024 | 4.43 Mn |
| Jun 30, 2024 | 2.54 Mn |
| Mar 31, 2024 | 2.99 Mn |
| Dec 31, 2023 | 3.52 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 4.56 Mn |
| Mar 31, 2023 | 5.16 Mn |
| Dec 31, 2022 | 5.74 Mn |
| Sep 30, 2022 | 6.39 Mn |
| Jun 30, 2022 | 6.44 Mn |
| Mar 31, 2022 | 7.23 Mn |
| Dec 31, 2021 | 1.21 Mn |
| Sep 30, 2021 | 1.41 Mn |
| Jun 30, 2021 | 1.77 Mn |